3SBio Company Description
3SBio wants to find a cure for a wide spread of ailments, including cancer and viral and autoimmune diseases. The biopharmaceutical company develops protein-based products for treating diseases in nephrology, oncology, cancer care, and other areas through its Shenyang Sunshine subsidiary. The company's flagship product, EPIAO, is used to increase the amount of red blood cells in patients with anemia. Its newest product, TPIAO, treats a chemotherapy-induced deficiency in blood platelets. Other products include Intefen and Inleusin for leukemia, hepatitis C, and kidney cancer. 3SBio markets its products primarily through distributors in China to physicians, hospitals, clinics, and dialysis centers.
View the Comprehensive Company Description for 3SBio
The Company Description provides a historical perspective of 3SBio's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of 3SBio's evolution in the marketplace.
